BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 18, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

The MDD Interview: In ranking life science clusters, firm focuses on variety of factors

Feb. 28, 2013
By Jim Stommen
Jones Lang LaSalle is a global financial and professional services firm specializing in commercial real estate services and investment management. It produces an annual Life Sciences Cluster Report that covers major global markets with a strong or quickly growing life sciences presence. The U.S. section of this year's report once again featured a ranking of metropolitan areas and this year added ranking scorecard of the 50 U.S. states and the District of Columbia.
Read More

Biotronik receives FDA nod for Lumax 740 DX System

Feb. 28, 2013
By Omar Ford

Mind over matter

Feb. 27, 2013
By Omar Ford
She was probably a little more than 5-feet-tall... and close to 160 pounds of pure muscle. On a day unlike any other, I crossed the path of this 60-year-old woman (though she doesn't look a day over 40) who is an avid bodybuilder, at the gym I often work out in. We were both headed to a piece of equipment to do pull-ups - I was by myself, she was with a cadre of women that she was training. As I was about to get on the machine she cut me off rather quickly and hopped on it before I...
Read More

Agreements/contracts: McKesson assists AMA with MDx test tracking

Feb. 27, 2013

Washington roundup: AdvaMed's Ubl reports plans to 'double down' on device tax repeal

Feb. 27, 2013
By Mark McCarty

Medtronic gets IDE nod for Native Outflow Tract TPV

Feb. 27, 2013
By Amanda Pedersen

No FDA for now in Europe, but CE mark rules face overhaul

Feb. 27, 2013
By John Brosky

Financings roundup: TearScience secures up to $70M in funding from HRP

Feb. 27, 2013
By Omar Ford
TearScience (Morrisville, North Carolina), a privately held firm, said that it has secured up to $70 million in funding from HealthCare Royalty Partners to fully implement commercialization efforts and establish the TearScience system as the "standard of care" for evaporative dry eye.
Read More

MDD's Oncology Extra

Feb. 27, 2013

Product Briefs

Feb. 27, 2013
Previous 1 2 … 3614 3615 3616 3617 3618 3619 3620 3621 3622 … 10247 10248 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 18, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Doctor with brain illustration, businessman with dollar sign illustration

    Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

    BioWorld
    Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
  • Illustration of tau accumulating in a neuron cell.

    Biogen AD drug shows tau, cognition benefit, despite trial miss

    BioWorld
    Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing